G F Kolb1, L Weißbach2. 1. Medizinische Klinik, Abteilung für Innere Medizin, Fachbereich Geriatrie, Geriatrische Onkologie, Bonifatius-Hospital Lingen, Akademisches Lehrkrankenhaus der Westfälischen Wilhelms-Universität Münster, Wilhelmstraße 13, 49808, Lingen (Ems), Deutschland. gerald.kolb@hospital-lingen.de. 2. Stiftung Männergesundheit, Berlin, Deutschland. weissbach@stiftung-maennergesundeheit.de.
Abstract
BACKGROUND: Increasing life expectancy means growing numbers of elderly survive the critical age for cardiac and vascular diseases only to later experience cancer and dementia. OBJECTIVES: Of the types of cancer affecting men, prostate cancer continues to be diagnosed early by prostate-specific antigen (PSA) screening. The clinical relevance and quality of life of those affected must be critically judged. Depending on life expectancy, active surveillance (AS) and watchful waiting (WW) will be increasingly used in geriatric patients. Risk stratification as guided by CGA facilitates the therapeutic decisions of urologists and spares metastatic castration-resistant prostate cancer patients from unnecessary and adverse overtreatment. By 2030, approximately 1.8 million people will have dementia. CONCLUSIONS: Thus, in the future, the health care system will have to treat an aging population, which will require the creation of increasing numbers of geriatric hospital departments and cooperative models between geriatrics and other specialties. The future training of medical students and continuing medical education must also be further developed to include aspects on aging. Only in this manner will it be possible to effectively confront the challenges associated with demographic change in the specialty of geriatrics.
BACKGROUND: Increasing life expectancy means growing numbers of elderly survive the critical age for cardiac and vascular diseases only to later experience cancer and dementia. OBJECTIVES: Of the types of cancer affecting men, prostate cancer continues to be diagnosed early by prostate-specific antigen (PSA) screening. The clinical relevance and quality of life of those affected must be critically judged. Depending on life expectancy, active surveillance (AS) and watchful waiting (WW) will be increasingly used in geriatric patients. Risk stratification as guided by CGA facilitates the therapeutic decisions of urologists and spares metastatic castration-resistant prostate cancerpatients from unnecessary and adverse overtreatment. By 2030, approximately 1.8 million people will have dementia. CONCLUSIONS: Thus, in the future, the health care system will have to treat an aging population, which will require the creation of increasing numbers of geriatric hospital departments and cooperative models between geriatrics and other specialties. The future training of medical students and continuing medical education must also be further developed to include aspects on aging. Only in this manner will it be possible to effectively confront the challenges associated with demographic change in the specialty of geriatrics.
Entities:
Keywords:
Dementia; Early diagnosis; Overdiagnosis; Overtreatment; Quality of life
Authors: G Kolb; K Breuninger; S Gronemeyer; D van den Heuvel; N Lübke; D Lüttje; A Wittrich; J Wolff Journal: Z Gerontol Geriatr Date: 2014-01 Impact factor: 1.281
Authors: Reinhold Haux; Andreas Hein; Gerald Kolb; Harald Künemund; Marco Eichelberg; Jens-E Appell; H-Jürgen Appelrath; Christian Bartsch; Jürgen M Bauer; Marcus Becker; Petra Bente; Jörg Bitzer; Susanne Boll; Felix Büsching; Lena Dasenbrock; Riana Deparade; Dominic Depner; Katharina Elbers; Uwe Fachinger; Juliane Felber; Florian Feldwieser; Anne Forberg; Matthias Gietzelt; Stefan Goetze; Mehmet Gövercin; Axel Helmer; Tobias Herzke; Tobias Hesselmann; Wilko Heuten; Rainer Huber; Manfred Hülsken-Giesler; Gerold Jacobs; Elke Kalbe; Arno Kerling; Timo Klingeberg; Yvonne Költzsch; Christopher Lammel-Polchau; Wolfram Ludwig; Michael Marschollek; Birger Martens; Markus Meis; Eike Michael Meyer; Jochen Meyer; Hubertus Meyer Zu Schwabedissen; Niko Moritz; Heiko Müller; Wolfgang Nebel; Franz J Neyer; Petra-Karin Okken; Julia Rahe; Hartmut Remmers; Lars Rölker-Denker; Meinhard Schilling; Birte Schöpke; Jens Schröder; Gisela C Schulze; Mareike Schulze; Sina Siltmann; Bianying Song; Jens Spehr; Enno-Edzard Steen; Elisabeth Steinhagen-Thiessen; Nele-Marie Tanschus; Uwe Tegtbur; Andreas Thiel; Wilfried Thoben; Peter van Hengel; Stefan Wabnik; Sandra Wegel; Olaf Wilken; Simon Winkelbach; Thorben Wist; Klaus-Hendrik Wolf; Lars Wolf; Melanie Zokoll-van der Laan Journal: Inform Health Soc Care Date: 2014 Sep-Dec Impact factor: 2.439
Authors: Frederik B Thomsen; Klaus Brasso; Laurence H Klotz; M Andreas Røder; Kasper D Berg; Peter Iversen Journal: J Surg Oncol Date: 2014-03-07 Impact factor: 3.454
Authors: Radoslav Chekerov; Philipp Harter; Stefan Fuxius; Lars Christian Hanker; Linn Woelber; Lothar Müller; Peter Klare; Wolfgang Abenhardt; Yoana Nedkova; Isil Yalcinkaya; Georg Heinrich; Harald Sommer; Sven Mahner; Pauline Wimberger; Dominique Koensgen-Mustea; Rolf Richter; Gülten Oskay-Oezcelik; Jalid Sehouli Journal: Gynecol Oncol Res Pract Date: 2017-03-07
Authors: Daniela Ohlendorf; Polyna Sosnov; Julia Keller; Eileen M Wanke; Gerhard Oremek; Hanns Ackermann; David A Groneberg Journal: Sci Rep Date: 2021-01-27 Impact factor: 4.379